What it is.
hUC-MSC exosomes are extracellular vesicles derived from human umbilical cord mesenchymal stem cells — harvested in a native liquid formulation that preserves the signaling integrity of the source material.
Unlike processed or lyophilized alternatives, a native liquid formulation maintains the full exosome cargo — proteins, growth factors, microRNA — in the state closest to how the body produces and uses them. The source tissue is whole umbilical cord, not adipose or bone marrow, giving the product a differentiated and clinically compelling profile.
All product is physician-directed and shipped directly to the clinic. Administration is managed by or under the direct supervision of the ordering licensed physician.
Clinical applications.
The MedRepsRX exosome product line is supported across seven clinical verticals, each with dedicated practitioner materials and protocol guidance.
The compliance standard.
The exosome product line is available exclusively to licensed healthcare practitioners. It is not sold direct-to-consumer. Every order flows through a licensed physician relationship, and all product ships to the clinic — not to the patient.
This structure is not a legal formality. It reflects the clinical reality that these products require practitioner-level evaluation, patient selection judgment, and informed consent. MedRepsRX supports this by providing practitioners with the documentation, protocol guides, and clinical resources to manage that obligation appropriately.
How to access it.
The exosome product line is available to partner practices through the MedRepsRX platform. Independent physicians, specialist practices, and chiropractic practices operating with physician integration through the APEX Protocol can all qualify.
Credentialing is required. Inquire below to start the practitioner verification process and receive product documentation, pricing, and clinical protocol materials.